User profiles for Joanne M. Langley
 | Joanne LangleyDalhousie University Verified email at dal.ca Cited by 12992 |
[HTML][HTML] Respiratory syncytial virus prefusion F protein vaccine in older adults
A Papi, MG Ison, JM Langley, DG Lee… - … England Journal of …, 2023 - Mass Medical Soc
Background Respiratory syncytial virus (RSV) is an important cause of acute respiratory
infection, lower respiratory tract disease, clinical complications, and death in older adults. There …
infection, lower respiratory tract disease, clinical complications, and death in older adults. There …
The impact of vaccination on coronavirus disease 2019 (COVID-19) outbreaks in the United States
…, LA Meyers, KM Neuzil, JM Langley… - Clinical Infectious …, 2021 - academic.oup.com
Background Global vaccine development efforts have been accelerated in response to the
devastating coronavirus disease 2019 (COVID-19) pandemic. We evaluated the impact of a 2-…
devastating coronavirus disease 2019 (COVID-19) pandemic. We evaluated the impact of a 2-…
2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea
…, TS Steiner, K Kotloff, JM Langley… - Clinical Infectious …, 2017 - academic.oup.com
These guidelines are intended for use by healthcare professionals who care for children
and adults with suspected or confirmed infectious diarrhea. They are not intended to replace …
and adults with suspected or confirmed infectious diarrhea. They are not intended to replace …
[HTML][HTML] Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in …
…, V Dzutseva, G Parveen, F Zhu, L Leppan, JM Langley… - The Lancet, 2022 - thelancet.com
Background The Ad5-nCoV vaccine is a single-dose adenovirus type 5 (Ad5) vectored vaccine
expressing the SARS-CoV-2 spike protein that was well-tolerated and immunogenic in …
expressing the SARS-CoV-2 spike protein that was well-tolerated and immunogenic in …
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial
…, S McNeil, M Dionne, M Dawar, G Ogilvie, M Krajden… - Jama, 2013 - jamanetwork.com
Importance Global use of human papillomavirus (HPV) vaccines to prevent cervical cancer
is impeded by cost. A 2-dose schedule for girls may be possible. Objective To determine …
is impeded by cost. A 2-dose schedule for girls may be possible. Objective To determine …
Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers
Background . Group A streptococcus (GAS) causes illness ranging from uncomplicated
pharyngitis to life-threatening necrotizing fasciitis, toxic shock, and rheumatic fever. Attempts to …
pharyngitis to life-threatening necrotizing fasciitis, toxic shock, and rheumatic fever. Attempts to …
The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at …
BJ Law, JM Langley, U Allen, B Paes… - The Pediatric …, 2004 - journals.lww.com
Background: Infants born at 33 through 35 completed weeks of gestation (33-35GA) are at
risk for severe respiratory syncytial virus (RSV) infection, and palivizumab prophylaxis lowers …
risk for severe respiratory syncytial virus (RSV) infection, and palivizumab prophylaxis lowers …
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial
…, KJ Ford, TM John, D Pace, LM Yu, JM Langley… - Jama, 2008 - jamanetwork.com
Context Immunization with a meningococcal tetravalent (serogroup ACWY) glycoconjugate
vaccine is recommended for all US adolescents. However, the currently licensed vaccine is …
vaccine is recommended for all US adolescents. However, the currently licensed vaccine is …
Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory …
…, D Stephens, JL Robinson, S Dobson, JM Langley… - The Journal of …, 1996 - Elsevier
OBJECTIVES: To describe differences in patients hospitalized with respiratory syncytial
virus (RSV) lower respiratory tract infection (LRI) at nine Canadian tertiary care hospitals. In …
virus (RSV) lower respiratory tract infection (LRI) at nine Canadian tertiary care hospitals. In …
Projecting demand for critical care beds during COVID-19 outbreaks in Canada
BACKGROUND: Increasing numbers of coronavirus disease 2019 (COVID-19) cases in
Canada may create substantial demand for hospital admission and critical care. We evaluated …
Canada may create substantial demand for hospital admission and critical care. We evaluated …
